CESAR 2012 (Central European Symposium on Antimicrobials and Antimicrobial Resistance) (CESAR 2012)
Venue: Hotel Zora
|Event Date/Time: Sep 23, 2012||End Date/Time: Sep 26, 2012|
|Registration Date: Sep 23, 2012|
|Early Registration Date: Jun 15, 2012|
|Abstract Submission Date: Jul 31, 2012|
It is our pleasure to invite you to the Central European Symposium on Antimicrobials and Antimicrobial Resistance CESAR 2012. This Symposium differs from the previous three CESARs in scope and topics of the program. The program of CESAR 2012 is extended with the topics complementary to the antimicrobial resistance. The participants will also have a chance and opportunity to present and discuss their scientific achievements and knowledge not only in the development of antimicrobial resistance, but also in the development of new antimicrobial drugs, their effectiveness, rational use of existing and new antimicrobial chemotherapeutics, unmet medical need for new antimicrobials, etc. Because of that, the name of this CESAR differs from the previous. CESAR 2012 is the Central European Symposium on Antimicrobials and Antimicrobial Resistance and it will take place on 23-26 September 2012 in PrimoÅ¡ten, Croatia.
Croatian Microbiological Society is organizing CESAR 2012 in collaboration with Microbiological Societies from Czech Republic, Slovakia and Hungary. FEMS has recognized CESAR 2012 as a Pan-European meeting. This recognition resulted with the FEMS Meeting Support Grant, and therefore CESAR 2012 will provide a number of student grants for attending the meeting.
At CESAR 2012, respected and internationally recognized speakers from Europe will have a talk and opportunity to discuss the antimicrobial resistance and health threatening problems caused by that microbial phenomenon. We all know that antimicrobial resistance increases and spreads daily. The antimicrobial drug development does not keep the pace with this rising problem. According to the Infectious Diseases Society of America (IDSA), 2 million people get bacterial infections each year. Of these, 90.000 die. In approximately 70 per cent of these infections, organisms that are resistant to at least one antimicrobial drug were involved. Every year in the European Union, Iceland and Norway, about 25.000 patients die from a serious resistant bacterial infection, most of them in hospitals. If we do not succeed to control and to effectively fight the resistant microbes, we will have to learn how to live in a world without effective antimicrobial drugs and effective treatment of infective diseases. Are we ready for that? This problem has to be addressed properly, now more than ever, before one should take care of usage on market available antimicrobials and prioritize the development of potent and effective new antimicrobial drugs. All of these problems will be addressed and discussed at Central European Symposium on Antimicrobials and Antimicrobial Resistance in PrimoÅ¡ten, 23-26 September 2012.
We look forward to meeting you, in hope that CESAR 2012 will offer an excellent opportunity for exchanging new ideas, and for beginning of new collaborations within a warm and pleasant surrounding of PrimoÅ¡ten, where all participants will enjoy inboth scientific and personal experience.
President of organizing committee President of scientific committee
CESAR 2012 CESAR 2012
Prof.dr. Roberto AntoloviÄ‡, PhD Prof.dr. Gordana MaraviÄ‡ VlahoviÄek, PhD